Non-Small Cell Lung Cancer

Sacituzumab govitecan combination misses progression-free survival endpoint in metastatic NSCLC

September 15, 2026

Sacituzumab govitecan (SG) plus pembrolizumab did not demonstrate a statistically significant improvement in progression-free survival compared with pembrolizumab…

BBusiness

Ivonescimab shows significant survival benefit for patients with PD-L1-positive NSCLC

September 15, 2026

Ivonescimab significantly prolonged overall survival compared with pembrolizumab as first-line treatment for patients with PD-L1-positive advanced non-small cell…

HHealth

MD Anderson trial challenges local consolidative therapy paradigm in NSCLC

September 12, 2026

Adding local consolidative therapy (LCT) after induction treatment with nivolumab plus ipilimumab did not improve overall survival or…

HHealth

Cancer cells found to use ketones as alternate fuel for growth

June 25, 2026

Our cells rely on tightly regulated signaling pathways to control when they grow, divide, and survive. When these…

HHealthcare

AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial

March 24, 2026

This large, multisite randomized study has shown that AI prioritization of CXRs did not improve the speed of…

HHealth

New feedback mechanism in the brain could open avenues for treating people with sleep disorders

March 3, 2026

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is…

HHealth

Additional lymph node evaluation needed during surgery to accurately identify lung cancer spread

February 1, 2026

Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation…

HHealth

Boosting PI31 to restore synaptic function and prevent neurodegeneration

December 19, 2025

Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States.…

HHealth

Study: SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade. Image Credit: KwangSoo Kim / Shutterstock

October 24, 2025

A new study reveals that SARS-CoV-2 mRNA vaccines can amplify immune checkpoint therapy in lung and skin cancers…

GGenetics

AI Model Finds Gene Targets and Drug Combos to Reprogram Diseased Cells

September 10, 2025

Credit: FlashMovie/Getty Images Traditional drug discovery has often followed the “one drug, one target” paradigm—developing compounds against individual…

HHealth

Adjuvant chemo-immunotherapy may benefit patients with resected stage IB–IIIA NSCLC, trial suggests

September 8, 2025

Interim results from the NADIM ADJUVANT Phase III trial, led by the Spanish Lung Cancer Group (GECP), suggest…

Sacituzumab govitecan combination misses progression-free survival endpoint in metastatic NSCLC

Ivonescimab shows significant survival benefit for patients with PD-L1-positive NSCLC

MD Anderson trial challenges local consolidative therapy paradigm in NSCLC

Targeting metabolic pathways could prevent relapse in KRAS-mutant cancers

AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial

Blocking growth hormone receptor may improve treatment response in lung cancer

Additional lymph node evaluation needed during surgery to accurately identify lung cancer spread

Study finds a new protein target against KRAS-driven non-small cell lung cancer

How COVID mRNA vaccines may make cancer treatments more effective

AI Model Finds Gene Targets and Drug Combos to Reprogram Diseased Cells

Adjuvant chemo-immunotherapy may benefit patients with resected stage IB–IIIA NSCLC, trial suggests